522 related articles for article (PubMed ID: 33294960)
1. Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro.
Vashum Y; Premsingh R; Kottaiswamy A; Soma M; Padmanaban A; Kalaiselvan P; Samuel S
Mol Biol Rep; 2021 Jan; 48(1):105-116. PubMed ID: 33294960
[TBL] [Abstract][Full Text] [Related]
2. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway.
Fan L; Zhang Y; Zhou Q; Liu Y; Gong B; Lü J; Zhu H; Zhu G; Xu Y; Huang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30401729
[TBL] [Abstract][Full Text] [Related]
3. Suppression of human breast cancer cell metastasis by coptisine in vitro.
Li J; Qiu DM; Chen SH; Cao SP; Xia XL
Asian Pac J Cancer Prev; 2014; 15(14):5747-51. PubMed ID: 25081696
[TBL] [Abstract][Full Text] [Related]
4. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells.
Vashum Y; Kottaiswamy A; Bupesh G; Singh RP; Kalaiselvan P; Thiagarajan K; Samuel S
Curr Mol Pharmacol; 2021; 14(6):1134-1145. PubMed ID: 33573566
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro.
Zhong ZF; Tan W; Tian K; Yu H; Qiang WA; Wang YT
Oncol Rep; 2017 Apr; 37(4):2016-2024. PubMed ID: 28184941
[TBL] [Abstract][Full Text] [Related]
7. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
[TBL] [Abstract][Full Text] [Related]
8. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
9. TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells.
Simeone AM; McMurtry V; Nieves-Alicea R; Saavedra JE; Keefer LK; Johnson MM; Tari AM
Breast Cancer Res; 2008; 10(3):R44. PubMed ID: 18474097
[TBL] [Abstract][Full Text] [Related]
10. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
[TBL] [Abstract][Full Text] [Related]
11. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells.
Lee HS; Seo EY; Kang NE; Kim WK
J Nutr Biochem; 2008 May; 19(5):313-9. PubMed ID: 17683926
[TBL] [Abstract][Full Text] [Related]
12. Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.
Li W; Liu Z; Zhao C; Zhai L
Oncol Rep; 2015 Sep; 34(3):1345-52. PubMed ID: 26134759
[TBL] [Abstract][Full Text] [Related]
13. VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells.
Li F; Li C; Zhang H; Lu Z; Li Z; You Q; Lu N; Guo Q
Toxicol Appl Pharmacol; 2012 Jun; 261(2):217-26. PubMed ID: 22538171
[TBL] [Abstract][Full Text] [Related]
14. Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
Park JH; Cho YY; Yoon SW; Park B
Int J Oncol; 2016 Sep; 49(3):1230-40. PubMed ID: 27573547
[TBL] [Abstract][Full Text] [Related]
15. Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling.
Cui H; Yuan J; Du X; Wang M; Yue L; Liu J
Oncol Rep; 2015 Mar; 33(3):1284-90. PubMed ID: 25522911
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
[TBL] [Abstract][Full Text] [Related]
19. Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-κB signaling pathway.
Wang J; Cui L; Feng L; Zhang Z; Song J; Liu D; Jia X
Oncol Rep; 2016 Sep; 36(3):1269-76. PubMed ID: 27461575
[TBL] [Abstract][Full Text] [Related]
20. Cisatracurium inhibits the proliferation, migration and invasion of breast cancer cells by regulating the expression of miR-3174.
Yang X; Ma W
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):1-7. PubMed ID: 33040777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
